+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

UK COVID-19 Diagnostics Market 2020-2026

  • ID: 5190209
  • Report
  • October 2020
  • Region: United Kingdom
  • Orion Market Research Private Limited
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abingdon Health Ltd.
  • AstraZeneca plc
  • Babylon Health
  • DnaNudge Ltd.
  • GlaxoSmithKline plc
  • Mologic Ltd.
  • MORE
UK COVID-19 Diagnostics Market Size, Share & Trends Analysis Report by Type (Instruments, Reagents & Kits, and Laboratory Testing Services), by Technology Type (PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test), by Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Blood, Urine, Saliva, and Others), and by End-Users (Laboratories, Hospitals, Diagnostic Centers & Clinics, and Research Institutes) and Forecast, 2020-2026
UK COVID-19 diagnostics market is estimated to see a decline in CAGR of 30.9% during the forecast period. UK is among the top five European countries in terms of the most prevalent COVID-19 incidences. As a result, a rapid surge in the demand for COVID-19 diagnostic tools has been reported in the country. During the period of March-May 2020, the country was facing a shortage of test kits which have increased the government’s focus to increase its testing capacity. In early May, the UK government layout another challenge to expand testing capacity to 200,000 tests per day by the end of May that was met on May 29, 2020, and constantly to be met daily. At 9 am on August 02, 2020, testing capacity was 338,413 in UK. As of 9 am on August 07, there have been 17,801,559 tests (either processed or sent out) across all 4 pillars in UK. Of these, 12,938,980 tests were processed in total (as per the UK Government). On July 08, 2020, UK has unveiled nearly37 billion packages aimed at saving jobs in the current scenario. On March 16, 2020, UK pledges almost400 billion of government-led loans and guarantees to support businesses through COVID-19. The country’s aid package comes after the same economic measures adopted in France, Italy, and Germany.

UK COVID-19 diagnostics market is segmented on the basis of technology type, end-use, sample type, and product type. By end-use, the COVID-19 diagnostic market is divided into laboratories, hospitals, diagnostic centers & clinics, and research institutes. By product type, the market is further segmented into instruments, reagents & kits, and laboratory testing services. By Sample type, the market is divided into oropharyngeal & nasopharyngeal swabs, blood, urine, saliva, and others. By technology type, the market is further segmented into PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test. Among these, the PCR segment has a major share in the COVID-19 diagnostics market. The factor that enhances the PCR test adoption includes a wide availability of tests and generation of the accurate results. However, due to its time consuming and expensive nature, these tests are substituted with other tests such as serology tests.

The companies which are contributing to the growth of the UK COVID-19 diagnostics market include Oxford Nanopore Technologies Ltd., Abingdon Health Ltd., Mologic Ltd., GlaxoSmithKline PLC, and AstraZeneca PLC. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market. For instance, in August 2020, UK government has placed orders for millions of high-speed COVID-19 test kits from DnaNudge (London, UK) and Oxford Nanopore Technologies (Oxford, UK) to be used in NHS hospitals from September 2020. The order will see 5.8 million lab-free, rapid and reliable PCR test from DnaNudge that delivers results in under 90 minutes and can work in about an hour being rolled out across the UK in urgent patient care and elective surgery settings, with further deployments in the out-of-hospital setting.

Research Methodology

The market study of the UK COVID-19 diagnostics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors.

Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.
The report provides an in-depth analysis of market size, various services offered by the players, and market opportunity. The report will serve as a source for 360-degree analysis of the market delivering insights for making better business decisions.

Market Segmentation

1. UK COVID-19 Diagnostics Market Research and Analysis by Type
2. UK COVID-19 Diagnostics Market Research and Analysis by Technology Type
3. UK COVID-19 Diagnostics Market Research and Analysis by Sample Type
4. UK COVID-19 Diagnostics Market Research and Analysis by End-User

The Report Covers
  • Comprehensive research methodology of the UK COVID-19 diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the UK COVID-19 diagnostics market.
  • Insights about market determinants which are stimulating the UK COVID-19 diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abingdon Health Ltd.
  • AstraZeneca plc
  • Babylon Health
  • DnaNudge Ltd.
  • GlaxoSmithKline plc
  • Mologic Ltd.
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. UK COVID-19 Diagnostics Market by Type
5.1.1. Instruments
5.1.2. Reagents & Kits
5.1.3. Laboratory Testing Services
5.2. UK COVID-19 Diagnostics Market by Technology Type
5.2.1. PCR Test
5.2.2. Antigen Test
5.2.2.1. Chromatographic Immunoassay
5.2.2.2. Fluorescent Immunoassay
5.2.2.3. Chemiluminescent Immunoassay
5.2.3. Serology Test
5.2.3.1. Enzyme-Linked Immunosorbent Assay (ELISA)
5.2.3.2. Neutralization
5.2.3.3. Chemiluminescent Immunoassay
5.2.4. Rapid/ PoC Test
5.3. UK COVID-19 Diagnostics Market by Sample Type
5.3.1. Oropharyngeal & Nasopharyngeal Swabs
5.3.2. Blood
5.3.3. Urine
5.3.4. Saliva
5.3.5. Others (Sperm)
5.4. UK COVID-19 Diagnostics Market by End-Users
5.4.1. Laboratories
5.4.2. Hospitals
5.4.3. Diagnostic Centers & Clinics
5.4.4. Research Institutes

6. Company Profiles
6.1. Abingdon Health Ltd.
6.2. AstraZeneca plc
6.3. Babylon Health
6.4. DnaNudge Ltd.
6.5. GlaxoSmithKline plc
6.6. Mologic Ltd.
6.7. Novacyt Group
6.8. Omega Diagnostics Group
6.9. Oxford Nanopore Technologies Ltd.
6.10. Surescreen Diagnostics Ltd.

List of Tables

List of Figures
Note: Product cover images may vary from those shown
3 of 3
  • Abingdon Health Ltd.
  • AstraZeneca plc
  • Babylon Health
  • DnaNudge Ltd.
  • GlaxoSmithKline plc
  • Mologic Ltd.
  • Novacyt Group
  • Omega Diagnostics Group
  • Oxford Nanopore Technologies Ltd.
  • Surescreen Diagnostics Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll